
Delcath Systems Reveals Positive Results from Independent Study on Repeated Hepatic Chemosaturation
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology firm specializing in liver cancer treatment, has announced the publication of an independent study by researchers at the University Hospital of Leipzig, Germany. Published in the European Society for Medical Oncology’s journal…












